0000914190-17-000238.txt : 20170815 0000914190-17-000238.hdr.sgml : 20170815 20170815164427 ACCESSION NUMBER: 0000914190-17-000238 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170812 FILED AS OF DATE: 20170815 DATE AS OF CHANGE: 20170815 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kummeth Charles R. CENTRAL INDEX KEY: 0001534980 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 171034341 MAIL ADDRESS: STREET 1: 425 MARTINGALE ROAD STREET 2: SUITE 1000 CITY: SCHAUMBURG STATE: IL ZIP: 60173-2213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-08-12 0000842023 BIO-TECHNE Corp TECH 0001534980 Kummeth Charles R. 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 1 1 0 0 Chief Executive Officer Common Stock 2017-08-12 4 M 0 9248 A 70278 D Stock Option (Right to Buy) 67.46 2020-04-01 Common Stock 65000 65000 D Stock Option (Right to Buy) 67.46 2020-04-01 Common Stock 50000 50000 D Stock Option (Right to Buy) 86.25 2021-04-01 Common Stock 46316 46316 D Stock Option (Right to Buy) 94.35 2017-08-12 4 A 0 66849 0 A 2021-08-12 Common Stock 66849 66849 D Stock Option (Right to Buy) 108.49 2022-08-07 Common Stock 79517 79517 D Stock Option (Right to Buy) 108.49 2022-08-07 Common Stock 119275 119275 D Restricted Stock Unit Common Stock 17283 17283 D Stock Option (Right to Buy) 106.59 2023-08-18 Common Stock 102779 102779 D Stock Option (Right to Buy) 106.59 2023-08-18 Common Stock 154169 154169 D Restricted Stock Unit Common Stock 24979 24979 D On August 12, 2014, the reporting person was granted 11,129 restricted stock units (previously reported). The restricted stock units would vest in full or in part on August 12, 2017 if certain performance goals were achieved during each of the 2015, 2016 and 2017 fiscal years. The performance criteria was determined, resulting in the restricted stock unit vesting as to 9,248 shares. Restricted stock units convert into common stock on a one-for-one basis. Includes (i) 10,203 shares for which the risk of forfeiture will lapse pursuant to achievement of performance goals; (ii) 3,841 shares for which the risks of forfeiture will lapse on August 7, 2018; and (iii) 16,653 shares for which the risks of forfeiture will lapse with respect to 5,551 shares on each of August 18, 2017, August 18, 2018 and August 18, 2019. Fully exercisable. The option will vest pursuant to the following schedule: 5,790 shares on October 1, 2014, 965 shares on the first day of the month for the period beginning November 1, 2014 and ending March 1, 2018, and 961 shares on April 1, 2018. Fully exercisable pursuant to achievement of performance goals. On August 12, 2014, the reporting person was granted an option to purchase 80,460 shares of common stock (previously reported). The option would vest in full or in part on August 12, 2017 if certain performance goals were achieved during each of the 2015, 2016 and 2017 fiscal years. The performance criteria was determined, resulting in the option vesting as to 66,849 shares. 19,879 shares vest on each of August 7, 2016, August 7, 2017 and August 7, 2018 and 19,880 shares vest on August 7, 2019. Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. Vests 25,695 shares on each of 8/18/17, 8/18/18, and 8/18/19 and 25,694 shares on 8/18/20. Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). /s/ Melodie R. Rose as Attorney-in-Fact for Charles R. Kummeth pursuant to Power of Attorney previously filed. 2017-08-15